Single infusion of monoclonal antibody effective for psoriasis. (Phase I Study).(Brief Article)
Publication: Skin & Allergy News
Publication Date: 01-JUL-03
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
MIAMI BEACH -- A single infusion of a monoclonal antibody that targets interleukin-12 substantially improved psoriasis at all dosages in a phase I, open-label study.
An antibody that blocks the action of the cytokine interleukin-12 has the potential to treat immune system--mediated inflammatory diseases such as psoriasis, multiple sclerosis,...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
